Ulcerative colitis

September 30, 2014September 30, 2014

Takeda’s CD and UC Therapy Receives Positive Reaction from U.S. Gastroenterologists

Crohn's Disease, News, Ulcerative colitis

One month after the launch of Entyvio, a new treatment for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD), the therapy is already becoming a popular prescription among gastroenterologists ... Read more

September 22, 2014September 22, 2014

Phase II Trial for Bertilimumab for Ulcerative Colitis Launched

IBD News, News, Ulcerative colitis

Massachusetts-based Immune Pharmaceuticals Inc., a company that specializes in creating antibody therapeutics for chronic inflammatory conditions, recently announced the start of participant screening for its Phase II clinical trial of one of ... Read more

September 22, 2014September 28, 2016

Salix’s UCERIS Granted Tentative FDA Approval for Distal Ulcerative Colitis

News, Ulcerative colitis

Salix Pharmaceuticals may soon bring a new treatment for mild-to-moderate distal ulcerative colitis to the market with its tentative Food and Drug Administration (FDA) approval for UCERIS (budesonide) rectal foam. ... Read more

September 18, 2014September 18, 2014

New Survey Suggests Biologics Could Be the New Vanguard For Treating Crohn’s Disease, Ulcerative Colitis

Crohn's Disease, News, Ulcerative colitis

In their latest report, entitled, “Crohn’s Disease and Ulcerative Colitis: U.S. Physician and Payer Perspectives on Established and Recently Launched Biologics, Emerging Novel Agents and Biosimilars,” Decision Resources, a Decision ... Read more

September 16, 2014

Obesity May Be Related To Around 20 Percent Of Gastric Diseases

IBD News, News, Ulcerative colitis

Around 20 percent of people in the United Arab Emirates suffer from gastric problems like acid reflux, ulcerative colitis and irritable bowel syndrome due to obesity and poor diets, which are also ... Read more

September 9, 2014September 9, 2014

Long-term Use of Adalimumab Yields Promising Benefits For Ulcerative Colitis Patients

News, Ulcerative colitis

According to a recent study, prolonged treatment with Adalimumab, a TNF inhibiting anti-inflammatory drug, is beneficial for patients with moderately to severely active ulcerative colitis (UC). The study was conducted at the University ... Read more

September 5, 2014September 5, 2014

Pediatric Ulcerative Colitis May Be Caused By Genetic Factors, UCLA Study Suggests

News, Ulcerative colitis

Early-onset of the severe inflammatory bowel disease ulcerative colitis may be caused by several genetic factors, according to a recent study conducted at the University of California, Los Angeles (UCLA). ... Read more

August 29, 2014September 28, 2016

ULTRA 1, 2, 3 Demonstrate Safety and Efficacy of Adalimumab in Ulcerative Colitis

News, Ulcerative colitis

Three clinical trials — one an open-label extension study, evaluating adalimumab (Humira) in patients with moderately to severely active ulcerative colitis — were recently reviewed in an article from collaborators at ... Read more

August 19, 2014August 19, 2014

Crohn’s Disease, UC Management Programs at CVS Caremark Included in NCQA Accreditation

Crohn's Disease, News, Ulcerative colitis

National pharmacy chain CVS Caremark recently received full NCQA Patient and Practitioner Oriented Disease Management (DM) accreditation by the Accordant Health Services division to start programs that will support a wide range of diseases, including ... Read more

August 7, 2014August 7, 2014

New York State Recognizes First Crohn’s and Colitis Awareness Month in NYC

Crohn's Disease, News, Ulcerative colitis

The city of New York announced that, for the first time ever, this August is Crohn’s and Colitis Awareness Month, after the approval of a resolution by the New York ... Read more